Results 231 to 240 of about 78,760 (307)

Transvenous Bullet Embolism: A Case Report of a Successful Right Ventricular "Bulletectomy". [PDF]

open access: yesJACC Case Rep
Toubat O   +8 more
europepmc   +1 more source

Single‐Incision Anterolateral Thoracotomy for LVAD Implantation: A Novel Minimally Invasive Approach

open access: yesArtificial Organs, EarlyView.
A novel single‐incision anterolateral thoracotomy technique enables complete HeartMate 3 implantation without sternotomy, minimizing surgical trauma and accelerating recovery. This minimally invasive approach is feasible, safe, and may represent a new standard in advanced heart failure surgery.
Ali Saad Merzah   +9 more
wiley   +1 more source

Temporary chest closure and open chest management for severe chest trauma: a retrospective study of 10 cases at a single hospital. [PDF]

open access: yesGen Thorac Cardiovasc Surg
Kayata H   +9 more
europepmc   +1 more source

Electrical Stimulation of Denervated Muscle: A Narrative Review

open access: yesArtificial Organs, EarlyView.
This review explores existing strategies for stimulating denervated muscle following lower motor neuron injury, including direct electrical stimulation of the muscle and artificial reinnervation to enable more comfortable and efficient indirect functional muscle stimulation.
Linshan Chu   +3 more
wiley   +1 more source

Reawakening of a dormant diaphragmatic hernia: a case of delayed post-traumatic presentation. [PDF]

open access: yesJ Surg Case Rep
Van Pham N   +6 more
europepmc   +1 more source

Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen‐Year Longitudinal Profile

open access: yesArtificial Organs, EarlyView.
Our study of 1026 LVAD implants revealed HeartWare had lower driveline infection rates than other LVAD types. In addition, severe diabetes was associated with higher risk, while older age and coronary artery disease were linked to a lower risk of driveline infections.
Anh Nguyen   +6 more
wiley   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

open access: yesArtificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir   +9 more
wiley   +1 more source

Attenuating pulmonary injury and inflammation with C5/CD14 inhibition therapy: results from a porcine polytrauma model with blunt chest trauma. [PDF]

open access: yesEur J Trauma Emerg Surg
Mert Ü   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy